AstraZeneca closes mega $39B Alexion buyout despite antitrust fears, making a splash in rare diseases
21st July 2021 Uncategorised 0 AstraZeneca closes mega $39B Alexion buyout despite antitrust fears, making a splash in rare diseases
nhigginsdunn
Wed, 07/21/2021 – 11:05
More: AstraZeneca closes mega B Alexion buyout despite antitrust fears, making a splash in rare diseases
Source: fierce